RBC Prospectus Supplement Filed

Ticker: RY · Form: 424B2 · Filed: 2026-04-06T14:16:02-04:00

Sentiment: neutral

Topics: debt-offering, prospectus-supplement, medium-term-notes

Related Tickers: RY

TL;DR

RBC filed a prospectus supplement for Medium-Term Notes, Series L. Debt issuance ongoing.

AI Summary

Royal Bank of Canada filed a 424B2 prospectus supplement on April 6, 2026, detailing the terms of its offering of Medium-Term Notes, Series L. The filing provides information on the specific notes being offered, including their interest rates, maturity dates, and other terms, as part of its ongoing debt issuance program.

Why It Matters

This filing indicates Royal Bank of Canada is actively managing its debt offerings, which can impact its capital structure and borrowing costs.

Risk Assessment

Risk Level: low — This is a standard prospectus supplement for debt issuance, not indicating any unusual risks for the company.

Key Players & Entities

FAQ

What is the purpose of a 424B2 filing?

A 424B2 filing is a prospectus supplement used to provide additional information about securities being offered to the public, supplementing a previously filed registration statement.

What specific type of security is Royal Bank of Canada offering in this filing?

Royal Bank of Canada is offering Medium-Term Notes, Series L, as detailed in the 424B2 prospectus supplement.

When was this prospectus supplement filed with the SEC?

This prospectus supplement was filed with the SEC on April 6, 2026.

What is the CIK number for Royal Bank of Canada?

The CIK number for Royal Bank of Canada is 0001000275.

Where is Royal Bank of Canada's principal executive office located?

Royal Bank of Canada's principal executive office is located at Royal Bank Plaza, 200 Bay Street, Toronto, Ontario, Canada M5J 2J5.

Filing Stats: 4,713 words · 19 min read · ~16 pages · Grade level 11.7 · Accepted 2026-04-06 14:16:02

Key Financial Figures

Filing Documents

From the Filing

The information in this preliminary pricing supplement is not complete and may be changed. This preliminary pricing supplement is not an offer to sell nor does it seek an offer to buy these securities in any jurisdiction where the offer or sale is not permitted. Registration Statement No. 333-275898 Filed Pursuant to Rule 424(b)(2) Subject to Completion. Dated April 6, 2026. Pricing Supplement to the Prospectus dated December 20, 2023 , the Series J Prospectus Supplement dated December 20, 2023 , the Underlying Supplement No. 1A dated May 16, 2024 and the Product Supplement No. 1B dated July 22, 2025 Royal Bank of Canada $ Digital MSCI EAFE ® Index-Linked Notes, due The notes will not bear interest. The amount that you will be paid on your notes on the stated maturity date (expected to be the second scheduled business day after the determination date) is based on the performance of the MSCI EAFE ® Index (which we refer to as the “underlier”) as measured from the trade date to and including the determination date (expected to be between 20 and 23 months after the trade date). If the final underlier level (defined below) on the determination date is greater than or equal to the threshold level of 87.50% of the initial underlier level (set on the trade date and expected to be the closing level of the underlier on the trade date), you will receive the threshold settlement amount (expected to be between $1,133.00 and $1,156.40 for each $1,000 principal amount of notes). However, if the final underlier level is less than the threshold level, the return on your notes will be negative. You could lose your entire investment in the notes. To determine your payment at maturity, we will calculate the underlier return, which is the percentage increase or decrease in the final underlier level from the initial underlier level. On the stated maturity date, for each $1,000 principal amount of notes, you will receive an amount in cash equal to: · if the underlier return is greater than or equal to -12.50% (the final underlier level is greater than or equal to 87.50% of the initial underlier level), the threshold settlement amount; or · if the underlier return is negative and is below -12.50% (the final underlier level is less than 87.50% of the initial underlier level), the sum of (i) $1,000 plus (ii) the product of (a) $1,000 times (b) approximately 1.1429 times (c) the sum of the underlier return plus 12.50% . This amount will be less than $1,000 and could be zero. The foregoing is only a brief summary of the terms of your notes. You should read the additional disclosure provided in this pricing supplement so that you may better understand the terms and risks of your investment. The initial estimated value of the notes determined by us as of the trade date, which we refer to as the initial estimated value, is expected to be between $963.50 and $993.50 per $1,000 principal amount of notes and will be less than the original issue price. The final pricing supplement relating to the notes will set forth the initial estimated value. The market value of the notes at any time will reflect many factors, cannot be predicted with accuracy and may be less than this amount. We describe the determination of the initial estimated value in more detail below. Your investment in the notes involves certain risks, including, among other things, our credit risk. See the section “Selected Risk Factors” beginning on page PS-8 of this pricing supplement. Original issue date: , 2026 Original issue price: 100.00% of the principal amount Underwriting discount: 0.00% of the principal amount Net proceeds to the issuer: 100.00% of the principal amount See “Supplemental Plan of Distribution (Conflicts of Interest)” on page PS-13 of this pricing supplement. The original issue price, underwriting discount and net proceeds to the issuer listed above relate to the notes we sell initially. We may decide to sell additional notes after the date of this pricing supplement, at issue prices and with underwriting discounts and net proceeds that differ from the amounts set forth above. The return (whether positive or negative) on your investment in the notes will depend in part on the issue price you pay for such notes. None of the Securities and Exchange Commission (the “SEC”), any state securities commission or any other regulatory body has approved or disapproved of the notes or passed upon the adequacy or accuracy of this pricing supplement. Any representation to the contrary is a criminal offense. The notes will not constitute deposits insured by the Canada Deposit Insurance Corporation, the U.S. Federal Deposit Insurance Corporation or any other Canadian or U.S. governmental agency or instrumentality. The notes are not bail-inable notes and are not subject to conversion into our common shares under subsection 39.2(2.3) of the Canada Deposit Insurance Corp

View on Read The Filing